Pear Therapeutics Announces $50 Million Credit Facility from Perceptive Advisors

Pear Therapeutics, Inc. (Pear or the Company) today announced that it closed a credit facility for up to $50 million from Perceptive Advisors (Perceptive), a leading life sciences investment firm.